Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    10973392 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas
Condition: Pancreatic Fistula
Intervention: Drug: Inj. Octreotide
2 Active, not recruiting Sandostatin in the Prevention of Postoperative Complications After Pancreaticoduodenectomy
Condition: Periampullary Carcinoma Resectable
Interventions: Drug: Octreotide;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.